Log in to save to my catalogue

EZH2 engages TGFβ signaling to promote breast cancer bone metastasis via integrin β1-FAK activation

EZH2 engages TGFβ signaling to promote breast cancer bone metastasis via integrin β1-FAK activation

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_05aa232c6afd450daf8510c54d82f59b

EZH2 engages TGFβ signaling to promote breast cancer bone metastasis via integrin β1-FAK activation

About this item

Full title

EZH2 engages TGFβ signaling to promote breast cancer bone metastasis via integrin β1-FAK activation

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2022-05, Vol.13 (1), p.2543-2543, Article 2543

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Bone metastases occur in 50–70% of patients with late-stage breast cancers and effective therapies are needed. The expression of enhancer of zeste homolog 2
(
EZH2) is correlated with breast cancer metastasis, but its function in bone metastasis hasn’t been well-explored. Here we report that EZH2 promotes osteolytic metastasis of breast cance...

Alternative Titles

Full title

EZH2 engages TGFβ signaling to promote breast cancer bone metastasis via integrin β1-FAK activation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_05aa232c6afd450daf8510c54d82f59b

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_05aa232c6afd450daf8510c54d82f59b

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-022-30105-0

How to access this item